baber/WOPTO huggingface dataset:
Patent AU-5948600-A (AU)
Title: Server for supporting the establishment of telephone calls through an IP network
Inventor: STAHL UWE
IPC: H04M7/00
Filed: 2000-09-18
Abstract: The connection method allows a voice connection between a subscriber (TE1,TE2) of an IP network (IPNET) and a telephone network subscriber (TE3,TE4,TE5), using an IP network server (SERV) identifying the required telephone network connection, for contacting a telephone network server (NPS) and diverting the call connection to a voice-over IP gateway (GW1-GW3). Also included are Independent claims for the following: (a) a server for providing a voice connection between an IP network subscriber and a telephone network subscriber; (b) a computer product for providing a voice connection between an IP network subscriber and a telephone network subscriber
Patent AU-6012699-A (AU)
Title: Method for the aerosol pulverisation of liquid perfuming products
Inventor: NERUSHAI SERGEI ALEXEEVICH
IPC: B65D83/36
Filed: 1999-09-15
Abstract: A method for aerosol spraying liquid perfume products consists of simultaneously spraying liquid perfume products and/or components of liquid perfume products, having different odors, in the form of aerosol streams into a region being treated. Aerosol spraying nozzles are placed proximate each other. The simultaneous spraying of at least two components of a liquid perfume product is carried out, and during the spraying the axes of the aerosol streams of the components are positioned at an angle to each other that ensures intersection of the aerosol streams. The spraying is carried out into at least three regions in which at least three different odors are obtained. Wherein, the third odor is formed in a region located between the first and second regions at the intersection of the aerosol streams of the two initial liquid perfume products. A microprocessor device is used to control the amount of the components of perfume liquids which are fed to micronozzles and from which different compositions of odors are formed, including odors which change in time.
Patent AU-6078298-A (AU)
Title: Method of inhibiting biosynthesis of EIf5A
Inventor: BERGERON RAYMOND J JR
IPC: A61P43/00
Filed: 1997-09-12
Abstract: Inhibition of the intracellular biosynthesis of EIf-5A comprises administration of a polyamine of formula R1N1(R2)(CH2)mN2(R3)(CH2)nN3(R4)(CH2)mN4(R5)R6 (I), R1N1H(CH2)vN2H(CH2)wN3H(CH2)xN4H(CH2)yN5H(CH2)zN6HR6 (I'), (I'') or (I''') in an amount sufficient to deplete the intracellular supply of spermidine (required for EIf-5A biosynthesis) but insufficient to affect polyamine homeostasis: R, R6 = H (except for (I)) alkyl or 1-12C aralkyl; R2-R5 = H, R1 or R6; R7 = H, alkyl, aryl or 1-12C aralkyl; m, n = 3-6; v-z = 3-10; R8-R13 = H, alkyl, aryl, arylalkyl or cycloalkyl such that any alkyl chains are optionally interrupted by >= 1 etheric O; N1-N4 = nitrogen atoms capable of protonation at physiological pH; a, b = 0-4, but both may not be 0; A-C = bridging groups which effectively maintain the distance between the N atoms such that the polyamine: (i) is capable of uptake by a target cell or is capable of binding to >= 1 polyamine site of a receptor located within or on the surface of a cell upon administration; (ii) upon uptake by the target cell, competitively binds via an electrostatic interaction between the positively charged nitrogen to biological counter-ions such that the polyamine on binding to the biological counter ion, functions in a manner biologically different from the intracellular polyamines; and where >= 1 of the bridging groups may contain >= 1 CH(OH) group which is not alpha to either of the nitrogen atoms.
Patent AU-6128399-A (AU)
Title: Hosiery retaining device and method
Inventor: NEUBAUER DEBORAH A
IPC: A47G25/74
Filed: 1999-04-06
Abstract: A device for retaining articles, such as hosiery, is disclosed. A method of retaining the articles using the device is also disclosed. The device generally comprises a first member and retaining means. The article to be retained upon the device is positioned upon the first member, such as by being wound around it.
Patent AU-6231986-A (AU)
Title: Method of and apparatus for producing superfine powder in spherical form
Inventor: WALZ ALFRED
IPC: B22F9/08
Filed: 1986-09-03
Abstract: Apparatus for producing superfine powder in spherical form with a diameter of about 5 to 30 microns in a laval nozzle system. The material to be powdered is melted in a crucible, and is then superheated after it emerges from the crucible.
Patent AU-6298498-A (AU)
Title: Collagenic material useful in particular for preventing post-operative adhe sions
Inventor: TAYOT JEAN-LOUIS
IPC: A61L31/00
Filed: 1998-02-05
Abstract: The present invention relates to a biocompatible collagenous material which is non-toxic and biodegradable in less than one month, preferably in less than one week. This material comprises collagen and at least one hydrophilic macromolecular additive which is chemically non-reactive towards the collagen, with the collagen having at least partially lost its helical structure and being crosslinked. The invention also relates to a process for obtaining such a material. The collagenous material according to the invention is used, in particular, for preventing post-operative adhesions.
Patent AU-6316596-A (AU)
Title: Powdered sweetener composition for animal feed
Inventor: FELISAZ DENIS
IPC: A23K1/18
Filed: 1996-07-19
Abstract: A powdered sweetener composition for animal feed containing an intimate mixture with a substantially uniform, non-statistical sweetener/potentiator distribution that is substantially constant in all particles. The particle size of the composition is particularly from 10 to 100 mum, and has a Gaussian distribution. The composition is particularly useful for preparing feed for young animals, e.g. piglets, in which case the sweetener is a saccharine salt and the potentiator is neohesperidine dihydrochalcone (NHDC), thaumatin or glycyrrhizin.
Patent AU-6344499-A (AU)
Title: Biological material for preparing pharmaceutical compositions for treating mammals
Inventor: ACRES BRUCE
IPC: A61K35/14
Filed: 1999-10-20
Abstract: The invention concerns a biological material for preparing pharmaceutical compositions for treating mammals including either a nucleic acid sequence, containing at least a gene of therapeutic interest and elements expressing the gene in vivo in target cells genetically modified by one such nucleic sequence, or at least a target cell not producing antibodies naturally, genetically modified in vitro by at least one such nucleic acid sequence. The gene of therapeutic interest codes for all or part of an antibody expressed at the surface of the target cell, and such an antibody is capable of fixing itself to a polypeptide present at the surface of a cytotoxic effector cell or a T lymphocyte helper involved in the process activating such a cell.
Patent AU-6498886-A (AU)
Title: Continuous release pharmaceutical compositions
Inventor: HUTCHINSON FRANCIS GOWLAND
IPC: C08G63/08
Filed: 1986-11-10
Abstract: Pharmaceutical compositions, comprising a polylactide and a pharmacologically active, acid stable polypeptide, which when placed in an aqueous physiological environment release the polypeptide at an approximately constant rate in an essentially monophasic manner, with a minimal, or no induction period prior to the release; polylactides suitable for use in said compositions; and a method for the manufacture of such polylactides.
Patent AU-6600990-A (AU)
Title: Method and device for the magnetic treatment of a fluid
Inventor: MERCIER DOMINIQUE
IPC: C02F1/48
Filed: 1990-10-12
Abstract: A process and a device for the magnetic treatment of fluid as the fluid moves in successive magnetic fields, including a sheet having adjacent transverse bands each of the same width. Each band is charged with magnets oriented alternatively NS/SN or NNSS/SSNN perpendicularly to the plane of the sheet so that successive transverse bands adjacent to each other present upper polar faces alternately having polarities S, N, S, N . . . S,N or S,S, N,N, S,S, N,N, . . . S,S, N,N.
Patent AU-6615496-A (AU)
Title: The preparation of active peptides
Inventor: AMBERG WILHELM
IPC: C07K5/06
Filed: 1996-07-12
Abstract: PCT No. PCT/EP96/03073 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/05162 PCT Pub. Date Feb. 13, 1997A process for preparing pentapeptides of the formula I where A and R1-R3 have the stated meanings, comprises assembling the pentapeptide stepwise starting from a prolinamide of the formula II where R1 and R2 have the abovementioned meanings, and eliminating the group -NR1R2 by hydrolysis where appropriate the peptide obtained in this way.
Patent AU-6643200-A (AU)
Title: Water soluble sdz-rad esters
Inventor: ZHU TIANMIN
IPC: A61K47/48
Filed: 2000-08-16
Abstract: The invention provides novel water soluble pegylated esters of rapamycin, having general structure (I), wherein n is an integer from about 5 to about 450, as well as pharmaceutical compositions containing these compounds and methods for their use as immunosuppressive, anti-inflammatory, antifungal, antiproliferative and antitumor agents.
Patent AU-6657894-A (AU)
Title: Osteogenesis promoter and osteoporosis remedy
Inventor: SUZUKI YASUO
IPC: A61K31/565
Filed: 1994-05-18
Abstract: An osteogenesis promoter and/or an osteoporosis remedy containing an androgen derivative represented by general formula (1) or a salt thereof as the active ingredient. In said formula (1), the broken lines indicate that the bonds containing the same represent each either a single or a double bond. The compound (1) activates osteoblasts, promotes osteogenesis and increases bone quantity, and hence it is used for treating a morbid condition of lowered osteogenesis due to aging, immobilization, administration of glucocorticoids, and so forth. Further it can increase bone quantity by the osteogenesis promoter effect thereof, so that it is useful for treating osteoporosis accompanying the above morbid condition or occurring after ovariectomy or menopause. <CHEM>   <MATH>
Patent AU-6720398-A (AU)
Title: Electronic ballast
Inventor: LUGER SIEGFRIED
IPC: H05B39/04
Filed: 1998-02-16
Abstract: The invention relates to an electronic ballast (EVG) operating at least one lamp (10), wherein a light sensor (20) for monitoring the brightness of a specific physical area (28) can be connected to said ballast. A control device (12) controls or adjusts the brightness of the lamp (10) according to the actual brightness value provided by the light sensor (20) and automatically recognizes whether the light sensor (20) is connected to the connection device (18a, 18b) when the electronic ballast is operated. If no light sensor (20) is connected, the brightness of the lamp (10) is controlled or adjusted according to externally supplied control data (Iextern).
Patent AU-6787190-A (AU)
Title: High-speed synchronous transmission line access terminal
Inventor: CZERWIEC RICHARD MARION
IPC: H04L12/52
Filed: 1990-12-10
Abstract: A terminal (22) for a telecommunications system provides access to one or two high-speed synchronous transmission lines (10, 12) by both low-speed transmission lines (16) and subscriber lines (20). A core moduled (24) includes interfaces (32) to the high-speed lines (10, 12), a time slot interchanger (34), an interface (42) to the low-speed transmission lines (16), processors (40) and overhead circuitry (40) for supporting the terminal (22). An access module (26) includes a plurality of line shelves (48) connected to subscriber lines (20), each line shelf (48) includes a pair of processors (68) and four time slot assignors (82). A multi-link serial bus (44) connects the time slot interchanger (34) to the access module (26) and to the low-speed interface (42) and provides close coupling between the processors (40) in the core module (24) and the line shelves (48). The processors (40) cooperate to groom subscriber information from said subscriber lines (20) to and from time slots in said high-speed feeder line (10, 12) and said low-speed transmission line (16). Subscriber information may also be groomed between time slots of the high-speed feeder line (10, 12) and the low-speed transmission lines (16) and between time slots within each subscriber line (20). <IMAGE>   <IMAGE> <IMAGE>
Patent AU-6933496-A (AU)
Title: Antagonists of the oncogenic activity of the MDM2 protein and their use in the treatment of cancers
Inventor: TOCQUE BRUNO
IPC: C07K16/00
Filed: 1996-09-02
Abstract: The present invention relates to the utilization of a compound capable of antagonizing at least partially the oncogenic activity of the protein Mdm2 for the preparation of a pharmaceutical composition intended more particularly to a treatment of cancers with no p53 context. It further relates to the viral vector comprising a nucleic acid sequence coding for a compound capable of inhibiting at least partially the oncogenic activity of the protein Mdm2, and to a corresponding pharmaceutical composition.
Patent AU-6965001-A (AU)
Title: Device for users having after-troubles resulting from damage to the central nervous system and/ of a locomotor apparatus of the body
Inventor: AVERIANOV ANDREI IGOREVICH
IPC: A61H3/00
Filed: 2001-06-21
Abstract: The proposed device is comprised of individual modules (A, B, C, D) adapted for being used independently. A first module (A) appears as a recliner (1) comprising two flexible spatially curved bands (2) having their first ends (3) interconnected and their second ends (5) secured on the respective band (2) to form two straps to be arranged on the patient's shoulders. A second module (B) is in fact a correcting corset (6) adapted for correcting the spine without applying a vertical load thereon, A third module (C) appearing as a means (16) for correcting the hip and shin comprises two flexible bandages (17, 18) for being fixed over and under the knee joint, respectively. A fourth module (D) is essentially a means (21) for correcting the ankle joint and toes and has a first flexible belt (22) and a second belt (22) adapted for being arranged on the ankle and foot, respectively, as well as a toe-plantar element (26). The device may have a fifth module (E) appearing as a means (34) for correcting an upper extremity, having two spatially curved flexible bands (36) adapted to be fixed over and under the elbow joint, respectively, and a flexible carpal element (38) adapted for being secured on the palm and for abducting the thumb. Each of the modules (A, B, C, D) is an independent device. An exterior surface of each module (A, B, C, D) (is made from a napped material adapted for use in the Velcro-type fastener. There are correcting-rotating elements (33) adapted for interconnecting the respective modules (B, C, D and E, A) with a possibility of their disconnection using connecting means (41) which have an engaging surface adapted for establishing a connection of the Velcro-type fastener at any place on the exterior surfaces of each of the modules (A, B, C, D) depending on the pathology the patient is suffering from. <IMAGE>
Patent AU-7247400-A (AU)
Title: A method of obtaining information on the identity of a caller in a terminal of a telephone communications network
Inventor: GENDRE YVES LE
IPC: H04M1/724
Filed: 2000-12-21
Abstract: The caller identification procedure has a software agent (14) in the terminal (10) which sends the caller telephone number over the public network (1) and internet to a WAP server with a request for caller identification information which can be repeated or sent to other servers until a response is received.
Patent AU-7256291-A (AU)
Title: Apparatus and method for building a foundation for uprights or for making passages therethrough
Inventor: TIIKKAINEN MATTI KALERVO
IPC: E02D5/38
Filed: 1991-02-25
Abstract: PCT No. PCT/FI91/00058 Sec. 371 Date Sep. 21, 1992 Sec. 102(e) Date Sep. 21, 1992 PCT Filed Feb. 25, 1991 PCT Pub. No. WO91/13225 PCT Pub. Date Sep. 5, 1991.An apparatus and a method for building a foundation for uprights, such as flagpoles, posts, pillars or the like, or for making passages e.g. for cables, tubes etc. The apparatus (1) includes a drive-shaft (3) equipped helical auger (2). The shaft (3) is provided with a tubular body portion (4,4a). The end of the body section (4a) facing the helical auger (2) is fitted with a conical section (5) tapering towards helical auger (2). Thus, when the apparatus is in operation, the tapered section (5) serves to compact a soil layer softened by the helical auger (2).
Patent AU-7279400-A (AU)
Title: Suspending clear cleansing formulation
Inventor: PAREDES ROSA MERCEDES
IPC: C11D1/02
Filed: 2000-08-23
Abstract: A shower gel formulation having a clear appearance is described which suspends insoluble particles, water insoluble liquids or bubbles and contains an acrylate copolymer, an anionic surfactant, a cationic polymer and, optionally, an amphoteric surfactant. The method of use of the clear shower gel is also described.
Patent AU-7310001-A (AU)
Title: Plastic container having a crystallinity gradient
Inventor: BOYD TIMOTHY J
IPC: B65D1/02
Filed: 2001-06-29
Abstract: A plastic container including a portion of a sidewall having an interior surface with an interior crystallinity, and an exterior surface with an exterior crystallinity. The interior crystallinity is greater than the exterior crystallinity. The higher crystallinity on the interior surface provides increased resistance to flavor scalping along the surface contacting the commodity, thereby minimizing flavor scalping of the commodities inside the plastic container.
Patent AU-7335300-A (AU)
Title: Treatment of fungal infections utilizing a fungal growth medium
Inventor: PIERARD GERALD
IPC: A61K9/70
Filed: 2000-08-29
Abstract: The present invention relates to a method of treating a topical fungus infection on a mammal comprising the steps of: topically applying to said fungus an amount of a fungal growth medium effective to induce said fungus from the dormant state into the vegetative state; and administering to said mammal a therapeutically effective amount of an antifungal agent.
Patent AU-7471698-A (AU)
Title: Intracellular production of hepatitis c e1 and e2 truncated polypeptides
Inventor: HOUGTON MICHAEL
IPC: C12N15/08
Filed: 1998-05-06
Abstract: Methods for obtaining recombinantly produced, C-terminally truncated, E1 and E2 polypeptides from cell lysates are disclosed. The intracellularly expressed truncated molecules display improved biological properties as compared to their secreted counterparts.
Patent AU-7574394-A (AU)
Title: TNF inhibitors
Inventor: WALLACH DAVID
IPC: C07K19/00
Filed: 1994-10-11
Abstract: Ligands to Tumor Necrosis Factor receptors (TNF-Rs) which inhibit the effect of TNF but not its binding to the TNF-Rs, and ligands interacting with other receptors of the TNF/NGF family, are provided together with methods of producing them.
Patent AU-7607591-A (AU)
Title: Stabilization of somatotropins and other proteins by modification of cysteine residues
Inventor: BUCKWALTER BRIAN LEE
IPC: C07K14/555
Filed: 1991-04-29
Abstract: The present invention relates to physiologically-active derivatized natural and recombinant mammalian and human proteins and polypeptides. The invention provides chemical methods for derivatizing natural and recombinantly-derived proteins or polypeptides containing cysteine residues, either naturally or through site specific mutageneses. The pharmaceutical compositions containing said derivatized proteins and/or polypeptides are formulated to provide stable, long-acting compositions of such proteins and/or polypeptides, previously difficult to achieve.
Patent AU-7673191-A (AU)
Title: Diagnostic technique
Inventor: MCCARTHY BRIAN JOSEPH
IPC: C12Q1/6841
Filed: 1991-04-11
Abstract: A method of diagnosis suitable e.g. for differentiating between hairs of different animals, is adapted to determine the source of a biological structure (e.g. the hair) by hybridising a species-specific probe to single stranded genetic material in situ within said structure whilst maintaining, or substantially maintaining, the integrity thereof. Double stranded genetic material within the structure may be accessed and rendered single stranded, groups are rendered unreactive that react with a polynucleotide probe other than likewise reactive groups comprised by the genetic material, the probe is hybridised with the single stranded genetic material and the structure screened for hybridisation.
Patent AU-7761598-A (AU)
Title: 20(s) camptothecin glycoconjugates
Inventor: LERCHEN HANS-GEORG
IPC: C07K5/068
Filed: 1998-05-04
Abstract: The present invention relates to glycoconjugates of 20(S)-camptothecin, in which a 3-O-methylated beta-L-fucose unit is linked to the 20-hydroxyl group of a camptothecin derivative via a thiourea-modified peptide spacer. The invention furthermore relates to processes for the preparation of the compounds according to the invention and to their use as medicaments, in particular in connection with oncoses.
Patent AU-7791198-A (AU)
Title: Grinding machine
Inventor: WITTERS GILBERT FILIPE MARIA
IPC: B24B41/047
Filed: 1998-05-27
Abstract: A grinding machine comprises a frame having a rotary casing that bears rotary holders for grinding discs, as well as a drive motor which is mounted on the frame and interacts with the casing and the holders to drive the machine. The drive motor is connected by means of a continuous flexible or articulated element to the holders for driving the latter in the direction of rotation, wherein at least one of the holders is coupled to the frame by means of a gear transmission, in order to bring the casing into rotation when said holder is driven.
Patent AU-7888694-A (AU)
Title: The administration of monoamine acridine in cholinergic neuronal deficit states
Inventor: SUMMERS WILLIAM KOOPMANS
IPC: A61K31/473
Filed: 1994-11-17
Abstract: A pharmaceutical composition for treatment of underlying nonpharmacologically induced central or peripheral nervous system cholinergic deficit state in humans comprising a monoamine acridine derivative of the formula: <CHEM> wherein R1 represents hydrogen, hydroxy, methyl, methoxy, ethyl or ethoxy; R1 and R2 together may form a double bond, R3 and R4 together may form a double bond, or R1, R2, R3 and R4 are all hydrogen; R5 represents hydrogen, hydroxy, methoxy or ethoxy; R6 represents hydrogen, hydroxy, methoxy or ethoxy; and R7 is without a substituent or R7 represents an oxygen atom, a C1-C20 alkyl radical or a radical selected from the group consisting of     -R-N(R)2, <CHEM> wherein each R is independently selected from C1-C20 alkyl; or a pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable inert carrier therefor; with the provisos that the monoamine acridine derivative is a compound in which (i) if R1, R2, R3, R4, R5 and R6 are each hydrogen, then R7 cannot be without a substituent, (ii) if R1 and R2 together form a double bond, R3 and R4 together form a double bond and R5 and R6 are each hydrogen, then R7 cannot be without a substituent, and (iii) if R3 and R4 together form a double bond and R7 is without a substituent, then R1 cannot be a hydrogen atom is provided. <IMAGE>